Topiramate
Product Images NDC 70934-133

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)
Chemical structure of topiramate, showing its molecular framework with multiple oxygen atoms and functional groups including sulfonamide and methyl groups.*
FDA Label Image

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)
A line graph showing cumulative rates for time to an event on the y-axis against time in days on the x-axis, with two distinct plotted lines and a noted p-value of 0.0002 indicating statistical comparison of the lines.*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency	(studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)
A bar chart comparing the change from baseline to double-blind phase in average weekly migraine days for placebo and Topamax (topiramate) at doses of 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 10 and Study 11). The chart shows larger decreases in migraine days with increasing doses of Topamax, with statistical significance indicated for doses 100 mg/day and 200 mg/day.*
FDA Label Image

70934 133 30 Master Bottle Label Approval Rev B 10 19

70934 133 30 Master Bottle Label Approval   Rev B 10 19
Topiramate Tablets USP 50mg bottle label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label indicates it contains 30 tablets, prescription only, with storage instructions and regulatory information including lot number and expiration date fields. The NDC number is 70934-133.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.